[Therapeutic use of stem cells]

Area of Science:

• * Cell biology and developmental biology.
• * Stem cell research and regenerative medicine.

Context:

• * Embryonic stem (ES) cells possess self-renewal, proliferation, and differentiation capabilities.
• * ES cells are derived from the inner cell mass of the blastocyst.
• * These cells maintain undifferentiated features in long-term cultures and can differentiate into various cell types.

Purpose:

• * To explore the potential of human embryonic stem cells (hESCs) in treating degenerative diseases.
• * To investigate therapeutic cloning as a method for generating patient-specific tissues, avoiding immune rejection.
• * To address the ethical and legal implications arising from the potential misuse of therapeutic cloning for reproductive purposes.

Summary:

• * Embryonic stem cells (ES cells) have remarkable properties for treating incurable diseases.
• * Therapeutic cloning, adapting nuclear transfer techniques, aims to derive patient-compatible ES cells from cloned blastocysts.
• * This process involves transferring a somatic cell nucleus into an enucleated oocyte to create patient-specific tissues.

Impact:

• * Potential to revolutionize regenerative medicine by providing patient-specific tissues for transplantation.
• * Highlights the critical need for ethical guidelines and legal frameworks surrounding human cloning technologies.
• * Raises significant societal debate on the boundaries between therapeutic applications and reproductive cloning.